Insulin pumps (continuous subcutaneous insulin infusion) Insulin pumps (continuous subcutaneous insulin infusion) Assess the patients suitability for insulin pump therapy
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
Look for products that meet UK regulatory standards with compliant labelling (including UK business details and batch/lot numbers)
The team here at Montare can help guide you to the best treatment for Mental Health and provide an assessment to determine the best care to fit your needs
Work with a GP, registered dietitian, or qualified medical weight management provider who can create a plan tailored to your needs and health history
Moreover, the data used for this model did not extend beyond 52 weeks, necessitating extrapolation
